文献速递肝胆胰外科围术期管理与 ERAS

全国观察性队列研究中全胰腺切除术后的死亡率

Mortality after total pancreatectomy in an observational nationwide cohort study.
PubMed 文献 · Br J Surg · 2025-01-01

基于德国全国DRG统计的回顾性观察研究,分析2010至2020年13 946例全胰腺切除术。院内总死亡率为22.0%,按术式类型1至4分别为15.6%、17.2%、31.5%和34.7%(P < 0.001)。医院手术量增加与所有切除术式的院内死亡率显著降低相关(P < 0.001)。

要点

  • 全胰腺切除术院内总死亡率为22.0%,术式越复杂死亡率越高。
  • 类型4(含动脉操作)死亡率达34.7%,类型3(多脏器切除)为31.5%。
  • 医院手术量增加与所有术式院内死亡率显著降低相关。

核心结论

  • 基于全国行政数据的全胰腺切除术后死亡率在不同医院间存在显著差异。
  • 需进一步分析更精细数据以理解全胰腺切除术的手术量-死亡率关系。

研究设计与样本

  • 基于德国全国诊断相关组(DRG)统计常规数据的观察性回顾性研究。
  • 分析2010至2020年所有全胰腺切除术,共13 946例患者,按四种术式分类。
  • 以院内死亡率为终点进行单因素和多因素分析。

主要发现

  • 13 946例患者中,类型1标准全胰腺切除术7060例(50.6%),类型2含静脉操作1682例(12.1%),类型3含多脏器切除3921例(28.1%),类型4含动脉操作1283例(9.2%)。
  • 3232例患者(23.2%)需要再次剖腹手术。
  • 院内总死亡率为22.0%(3072例),类型1为15.6%(1102例),类型2为17.2%(290例),类型3为31.5%(1235例),类型4为34.7%(445例),P < 0.001。
  • 最差结局为60.7%院内死亡率,见于2010-2020年间在实施1至10例类型4全胰腺切除术的医院中手术的56例患者小亚组。
  • 随着手术量增加,所有切除术式的院内死亡率显著降低(P < 0.001)。

临床怎么用

  • 全胰腺切除术复杂度越高(类型3、4)院内死亡风险越高,术前应充分评估。
  • 医院手术量可能与全胰腺切除术后死亡率相关,高手术量医院结局更优。

局限性

  • 研究基于行政数据,可能存在编码偏倚和混杂因素。
  • 缺乏更精细的临床数据以深入分析手术量-死亡率关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As a result of adjuvant therapies for pancreatic cancer including new techniques, such as arterial divestment, and, for instance, as a result of more main-duct intraductal papillary mucinous neoplasms being diagnosed, the number of total pancreatectomies is increasing. Results of these complex operations are only available as centre analyses. The aim of this study was to analyse mortality after total pancreatectomy using real-world data. METHODS: An observational retrospective study based on routine data of the nationwide German diagnosis-related group (DRG) statistics was performed. All total pancreatectomies from 2010 to 2020 were analysed and classified into four types. Univariable and multivariable analyses were performed for in-hospital mortality as the endpoint. RESULTS: During the study interval, 13 946 patients underwent total pancreatectomy; 7060 patients (50.6%) underwent type 1 standard total pancreatectomy, 1682 patients (12.1%) underwent type 2 total pancreatectomy (included venous procedures), 3921 patients (28.1%) underwent type 3 total pancreatectomy (included multivisceral resections), and 1283 patients (9.2%) underwent type 4 total pancreatectomy (included arterial procedures). Relaparotomy was necessary for 3232 patients (23.2%). Overall, the in-hospital mortality rate was 22.0% (3072 patients), which varied depending on the type of total pancreatectomy (type 1, 15.6% (1102 patients); type 2, 17.2% (290 patients); type 3, 31.5% (1235 patients); and type 4, 34.7% (445 patients); P < 0.001). The worst outcome of 60.7% in-hospital mortality was related to a small subgroup of 56 patients who were operated on in hospitals that performed one to ten type 4 total pancreatectomies in 2010-2020. With increasing caseload, in-hospital mortality significantly decreased (P < 0.001) for all resection types. CONCLUSION: The mortality after total pancreatectomy differs significantly between hospitals based on nationwide administrative data across all hospitals. Further in-depth analysis of more granular data to understand the case volume-mortality relationship for total pancreatectomy is warranted.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Mantke R, Weber U, Schildberg C, et al. Mortality after total pancreatectomy in an observational nationwide cohort study. Br J Surg. 2025. PMID: 40458937. doi:10.1093/bjs/znaf091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。